Remifentanil Hydrochloride Structural Formula (Image 01)
Ultiva Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-913
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ultiva (NDC 67457-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Recovery Of Respiratory Drive After Equipotent* Doses Of Ultiva And Alfentanil Using Co2-stimulated Minute Ventilation In Adult Volunteers (±1.5 Sem) (Image 02)
Figure 2: Mean Concentration (sd) Versus Time (Image 03)
The text seems to represent a table containing two drugs, Alentril and ULTVA, and their respective doses measured in units of milligrams per minute. The table also includes a graph with time in minutes on the x-axis and dosage on the y-axis. However, the table and graph are incomplete and the context is not available, so a more specific description cannot be provided.*
Ultiva Injection 1 mg Carton Label (Image 04)
Ultiva Remifentanil HCL for Injection is an intravenous medication that is recommended to be administered at a concentration of 25,50, or 50 g/l. The package of Ultiva Remifentanil HCL for Injection contains 10x1mgSingle Doelials, and it is intended for intravenous use only. Any other information could not be retrieved as the text is unclear.*
Ultiva Injection 2 mg Carton Label (Image 05)
Ultiva Injection 5 mg Carton Label (Image 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
